Placebo 0 mg/1 mL Solution for infusion/injection, VAY736
CVAY736B2201
Phase 3 small_molecule active
Quick answer
Placebo 0 mg/1 mL Solution for infusion/injection, VAY736 for Autoimmune hepatitis is a Phase 3 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- Autoimmune hepatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active